Therapeutic efficacy of cannabidiol on pruritus and pain in children with recessive dystrophic epidermolysis bullosa: a pilot study
This prospective pilot interventional study aimed at studying the efficacy of cannabidiol on pruritus and pain on paediatric patients with recessive dystrophic epidermolysis bullosa. A decrease in average chronic pruritus and pain, pruritus and pain during dressing changes in addition to a significant improvement of quality-of-life scores and sleep were observed. No severe side effects were reported.
Authors
- N. Bellon (ORCID: https://orcid.org/0000-0003-3311-1674)
- Céline Greco (ORCID: https://orcid.org/0000-0003-4259-6861)
- Pauline Bataille (ORCID: https://orcid.org/0000-0002-6975-5941)
- Lara Mayrand
- Fabienne Marquant
- J. Bonigen (ORCID: https://orcid.org/0000-0001-5362-5694)
- Christine Bodemer (ORCID: https://orcid.org/0000-0001-8772-0905)
- S. Chaumon
- N. Schinkel
- Caroline Elie
- Imène Fettouche
Institutions
- Hôpital Necker-Enfants Malades (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Institut Necker Enfants Malades (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut des Maladies Génétiques Imagine (FR)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1093/bjd/ljaf400
- Primary Topic
- Transgenic Plants and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00